BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gasparetto M, Pescarin M, Guariso G. Helicobacter pylori Eradication Therapy: Current Availabilities. ISRN Gastroenterol. 2012;2012:186734. [PMID: 22900197 DOI: 10.5402/2012/186734] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Fan HY, Wang J, Yan GC, Huo XH, Mu LJ, Chu JK, Niu WW, Duan ZY, Ma JC, Wang J, Wang ZY. Increasing gastric juice pH level prior to anti-Helicobacter pylori therapy may be beneficial to the healing of duodenal ulcers. Exp Ther Med 2013;5:912-6. [PMID: 23408776 DOI: 10.3892/etm.2013.880] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yeo YH, Hsu CC, Lee CC, Ho HJ, Lin JT, Wu MS, Liou JM, Wu CY; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication. J Gastroenterol Hepatol 2019;34:59-67. [PMID: 30169908 DOI: 10.1111/jgh.14462] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
3 Navarro-Rodriguez T, Silva FM, Barbuti RC, Mattar R, Moraes-Filho JP, de Oliveira MN, Bogsan CS, Chinzon D, Eisig JN. Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study. BMC Gastroenterol. 2013;13:56. [PMID: 23530767 DOI: 10.1186/1471-230x-13-56] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
4 Nijevitch AA, Idrisov B, Akhmadeeva EN, Graham DY. Choosing optimal first-line Helicobacter pylori therapy: a view from a region with high rates of antibiotic resistance. Curr Pharm Des 2014;20:4510-6. [PMID: 24180406 DOI: 10.2174/13816128113196660728] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
5 Ofori EG, Adinortey CA, Bockarie AS, Kyei F, Tagoe EA, Adinortey MB. Helicobacter pylori Infection, Virulence Genes' Distribution and Accompanying Clinical Outcomes: The West Africa Situation. Biomed Res Int 2019;2019:7312908. [PMID: 31886245 DOI: 10.1155/2019/7312908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lee KH, Park SY, Jeong SJ, Jung DH, Kim JH, Jeong SH, Kang IM, Song YG. Can Aminoglycosides Be Used as a New Treatment for Helicobacter pylori? In vitro Activity of Recently Isolated Helicobacter pylori. Infect Chemother 2019;51:10-20. [PMID: 30941933 DOI: 10.3947/ic.2019.51.1.10] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
7 Zhang M. High antibiotic resistance rate: A difficult issue for Helicobacter pylori eradication treatment. World J Gastroenterol. 2015;21:13432-13437. [PMID: 26730153 DOI: 10.3748/wjg.v21.i48.13432] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 23] [Article Influence: 6.4] [Reference Citation Analysis]
8 Seddik H, Ahid S, El Adioui T, El Hamdi FZ, Hassar M, Abouqal R, Cherrah Y, Benkirane A. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study. Eur J Clin Pharmacol. 2013;69:1709-1715. [PMID: 23695545 DOI: 10.1007/s00228] [Reference Citation Analysis]
9 Wang J, Zhang G, Hu X, Liu Y, Bao Z, Huang Y. Two-week triple therapy has a higher Helicobacter pylori eradication rate than 1-week therapy: A single-center randomized study. Saudi J Gastroenterol 2015;21:355-9. [PMID: 26655129 DOI: 10.4103/1319-3767.170951] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
10 Guariso G, Gasparetto M. Update on Peptic Ulcers in the Pediatric Age. Ulcers 2012;2012:1-9. [DOI: 10.1155/2012/896509] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Hafeez M, Qureshi ZA, Khattak AL, Saeed F, Asghar A, Azam K, Khan MA. Helicobacter Pylori Eradication Therapy: Still a Challenge. Cureus 2021;13:e14872. [PMID: 34113506 DOI: 10.7759/cureus.14872] [Reference Citation Analysis]
12 Zakaria ZA, Balan T, Mamat SS, Mohtarrudin N, Kek TL, Salleh MZ. Mechanisms of gastroprotection of methanol extract of Melastoma malabathricum leaves. BMC Complement Altern Med 2015;15:135. [PMID: 25927982 DOI: 10.1186/s12906-015-0638-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
13 Navarro-Rodriguez T, Silva FM, Barbuti RC, Mattar R, Moraes-Filho JP, de Oliveira MN, Bogsan CS, Chinzon D, Eisig JN. Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study. BMC Gastroenterol. 2013;13:56. [PMID: 23530767 DOI: 10.1186/1471-230x-13-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
14 Iannuccelli V, Maretti E, Montorsi M, Rustichelli C, Sacchetti F, Leo E. Gastroretentive montmorillonite-tetracycline nanoclay for the treatment of Helicobacter pylori infection. Int J Pharm 2015;493:295-304. [PMID: 26238817 DOI: 10.1016/j.ijpharm.2015.06.049] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
15 Brito SA, de Almeida CLF, de Santana TI, da Silva Oliveira AR, do Nascimento Figueiredo JCB, Souza IT, de Almeida LL, da Silva MV, Borges AS, de Medeiros JW, da Costa Silva Neto J, de Cássia Ribeiro Gonçalves R, Kitagawa RR, Sant'Ana AEG, Rolim LA, de Menezes IRA, da Silva TG, Caldas GFR, Wanderley AG. Antiulcer Activity and Potential Mechanism of Action of the Leaves of Spondias mombin L. Oxid Med Cell Longev 2018;2018:1731459. [PMID: 29854075 DOI: 10.1155/2018/1731459] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
16 Seddik H, Ahid S, El Adioui T, El Hamdi FZ, Hassar M, Abouqal R, Cherrah Y, Benkirane A. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: A prospective randomized study. Eur J Clin Pharmacol. 2013;69:1709-1715. [PMID: 23695545 DOI: 10.1007/s00228-013-1524-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
17 Kim SY, Choi DJ, Chung JW. Antibiotic treatment for Helicobacter pylori: Is the end coming? World J Gastrointest Pharmacol Ther. 2015;6:183-198. [PMID: 26558152 DOI: 10.4292/wjgpt.v6.i4.183] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]